Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2007

View Archived Issues

Utility of I-123 MIBG in diagnosis of neuroblastomas

AZ-001 meets two-hour pain-relief endpoint in migraine

Topline results for CRx-139 in RA

Recent patents cover new therapeutic agents for cancer

Recent University of Dundee patent describes novel wound-healing agents

New therapeutic agents for gastrointestinal disorders reported in recent patents

New experimental data on sildenafil-doxazosin combination

INO-1001 evaluated in phase II study

BAY-68-4986 reduces heart rate in chronic angina patients

BMS-695735: a novel, improved IGF-1R inhibitor reported by BMS

ABT-888, a new PARP inhibitor, shows antitumor activity in several cancer models

Azixa studied in phase II for melanoma patients with brain metastases

AL-108 cleared for clinical study in schizophrenia-related cognitive impairment

Phase II trial evaluates belinostat with bortezomib in refractory multiple myeloma

HZT-501 begins phase II program for mild to moderate pain relief

Neugranin begins phase I/IIa study for neutropenia

United Therapeutics and Mochida sign Japanese agreement for Remodulin

CytoGenix and USAMRIID collaborate on biodefense vaccines

Phase IIb kidney transplant trial of ISA-247 clears interim review

Zyvox increases risk of death in patients with Gram-negative infections

BrainCells and Lundbeck form CNS research collaboration

Collaborative compound PS-386113 begins phase I for inflammatory disease

Phase III trial evaluates Zingo in adults

FDA accepts for review PMA for Repel-CV

Merck and Lundbeck discontinue gaboxadol development

BLA submission for Cervarix

GSK files Globorix meningococcal vaccine

E.U. approval for Xeloda for advanced stomach cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...